SEC Company Response from Century Therapeutics, (IPSC) — Jan 7, 2026
Century Therapeutics, Inc.
Date: Jan. 7, 2026 · CIK: 0001850119 · Accession: 0001104659-26-001760
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288616
Letter
Century Therapeutics, Inc.
25 North 38th Street, 11th Floor Philadelphia, Pennsylvania 19104
January 7, 2026
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-7553
Re: Century Therapeutics, Inc.
Registration Statement on Form S-3 Filed July 10, 2025 (File No. 333-288616)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Century Therapeutics, Inc. (the " Company ") hereby requests that the effective date of the Company's Registration Statement on Form S-3 (File No. 333-288616) (the " Registration Statement ") be accelerated so that the Company's Registration Statement will become effective at 4:01 P.M., Eastern Time, on January 9, 2026, or as soon thereafter as is practicable.
Please contact Jennifer L. Porter, Esq. of Goodwin Procter LLP, counsel to the Company, at (445) 207-7806 to provide notice of effectiveness, or if you have any questions or comments concerning this request.
[ Remainder of the page intentionally left blank ]
Very truly yours,
CENTURY THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm Century Therapeutics, Inc. 25 North 38th Street, 11th Floor Philadelphia, Pennsylvania 19104 January 7, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-7553 Re: Century Therapeutics, Inc. Registration Statement on Form S-3 Filed July 10, 2025 (File No. 333-288616) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Century Therapeutics, Inc. (the " Company ") hereby requests that the effective date of the Company's Registration Statement on Form S-3 (File No. 333-288616) (the " Registration Statement ") be accelerated so that the Company's Registration Statement will become effective at 4:01 P.M., Eastern Time, on January 9, 2026, or as soon thereafter as is practicable. Please contact Jennifer L. Porter, Esq. of Goodwin Procter LLP, counsel to the Company, at (445) 207-7806 to provide notice of effectiveness, or if you have any questions or comments concerning this request. [ Remainder of the page intentionally left blank ] Very truly yours, CENTURY THERAPEUTICS, INC. By: /s/ Brent Pfeiffenberger, Pharm.D. Name: Brent Pfeiffenberger, Pharm.D. Title: President and Chief Executive Officer